Shanghai Medicilon (SHSE:688202) 3-Year Revenue Growth Rate : 24.90% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai Medicilon 3-Year Revenue Growth Rate?

Shanghai Medicilon's Revenue per Share for the three months ended in Dec. 2023 was ¥1.30.

During the past 12 months, Shanghai Medicilon's average Revenue per Share Growth Rate was -21.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 24.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 30.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 10 years, the highest 3-Year average Revenue per Share Growth Rate of Shanghai Medicilon was 42.80% per year. The lowest was 19.70% per year. And the median was 25.40% per year.

Competitive Comparison of Shanghai Medicilon's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Shanghai Medicilon's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Medicilon's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Medicilon's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Medicilon's 3-Year Revenue Growth Rate falls into.

Shanghai Medicilon 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Shanghai Medicilon (SHSE:688202) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Shanghai Medicilon 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Medicilon's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Medicilon (SHSE:688202) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Medicilon Inc (SHSE:688202) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 67, Libing Road, Building 5, Pilot Free Trade Zone, Shanghai, CHN, 201299

Website

http://www.medicilon.com.cn

Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.

Shanghai Medicilon (SHSE:688202) Headlines

No Headlines